Title : Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.

Pub. Date : 2016 Apr 19

PMID : 26824324






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin inhibits 17beta-estradiol-induced epithelial-to-mesenchymal transition via betaKlotho-related ERK1/2 signaling and AMPKalpha signaling in endometrial adenocarcinoma cells. Metformin mitogen-activated protein kinase 3 Homo sapiens
2 In addition, metformin increased the expression of betaKlotho, a fibroblast growth factors (FGFs) coreceptor, and decreased ERK1/2 phosphorylation in both Ishikawa and KLE cells. Metformin mitogen-activated protein kinase 3 Homo sapiens
3 In conclusion, metformin abolishes 17beta-estradiol-induced cell proliferation and EMT in endometrial adenocarcinoma cells by upregulating betaKlotho expression, inhibiting ERK1/2 signaling, and activating AMPKalpha signaling. Metformin mitogen-activated protein kinase 3 Homo sapiens